Detection Windows: Assays vs Functional Clearance
Detection in biological assays does not equal functional activity. Standard immunoassays can detect peptide fragments or metabolites for hours after the peptide has stopped producing biological effects. For CJC-1295 no DAC, plasma levels drop below the thresho
This comparison does not assign a generated winner or score.
- Detection in biological assays does not equal functional activity. Standard immunoassays can detect peptide fragments or metabolites for hours after the peptide has stopped producing biological effects. For CJC-1295 no DAC, plasma levels drop below the threshold of most clinical assays within 6–8 hours, but ultra-sensitive mass spectrometry methods have detected trace metabolites up to 12 hours post-dose in research settings.
- Ipamorelin's detection window is even narrower. Plasma concentrations fall below quantifiable limits within 3 hours using high-performance liquid chromatography (HPLC). The World Anti-Doping Agency (WADA) lists growth hormone secretagogues as prohibited substances, but the short detection window makes enforcement difficult. Urine-based assays typically detect Ipamorelin for only 4–6 hours post-administration, and plasma assays are effective for 2–3 hours.
- Functional clearance. The point at which the peptide stops occupying receptors and driving GH release. Occurs faster than assay detection. Once plasma concentrations drop below the receptor activation threshold (typically within 2 hours), the peptide is biologically inactive even if trace amounts remain detectable. This is the practical clearance window that dictates dosing frequency.
- The key distinction: 'staying in your system' from a detection standpoint is irrelevant to research outcomes. What matters is the duration of receptor occupancy and GH pulse generation. Both of which end within 90–120 minutes regardless of trace plasma levels. Our work with research institutions has consistently shown that attempting to extend dosing intervals beyond 8–12 hours based on detection data rather than biological activity leads to suboptimal GH pulsatility patterns.